Corcept Therapeutics (CORT) Earnings Date, Estimates & Call Transcripts $76.22 +1.40 (+1.87%) As of 04:00 PM Eastern Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Corcept Therapeutics Earnings Summary Corcept Therapeutics issued Q1 2025 earnings on May 5, 2025, reporting an EPS of $0.17, which met the consensus estimate of $0.17. Quarterly revenue rose 7.1% year-over-year to $157.21 million, below analyst estimates of $177.93 million. With a trailing EPS of $1.16 and a P/E Ratio of 60.49, Corcept Therapeutics' earnings are expected to grow 36.03% next year, from $1.36 to $1.85 per share. Upcoming Q2 Earnings DateAug. 4After Market ClosesEstimatedConsensus EPS (May. 5) $0.17 Actual EPS (May. 5) $0.17 Actual Revenue (May. 5) $157.21MQ1 2025 Earnings ResourcesQ1 2025 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Quarterly Report (10-Q)CORT Upcoming EarningsCorcept Therapeutics' next earnings date is estimated for Monday, August 4, 2025, based on past reporting schedules. Powered by Get Corcept Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Corcept Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataCORT Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.CORT Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Corcept Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateRevenue EstimateCompany Revenue GuidanceQ1 20252$0.16$0.17$0.17Q2 20252$0.08$0.37$0.23Q3 20252$0.32$0.47$0.40Q4 20252$0.63$0.70$0.67 FY 2025 8 $1.19 $1.71 $1.45 Q1 20261$0.47$0.47$0.47Q2 20261$0.68$0.68$0.68Q3 20261$0.83$0.83$0.83Q4 20261$0.91$0.91$0.91 FY 2026 4 $2.89 $2.89 $2.89 Q1 20271$0.59$0.59$0.59 Corcept Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 8/4/2025(Estimated)--------5/5/2025Q1 2025$0.17$0.17-$0.17$177.93M$157.21M2/26/2025Q4 2024$0.37$0.26 -$0.11$0.26$200.12M$181.89M10/30/2024Q3 2024$0.27$0.41+$0.14$0.41$171.97M$182.55M7/29/2024Q2 2024$0.23$0.32+$0.09$0.32$155.14M$163.80M5/1/2024Q1 2024$0.21$0.25+$0.04$0.25$141.19M$146.80M2/15/2024Q4 2023$0.25$0.28+$0.03$0.28$129.27M$135.41M11/1/2023Q3 2023$0.22$0.28+$0.06$0.28$119.71M$123.60M8/2/2023Q2 2023$0.15$0.25+$0.10$0.25$109.60M$117.72M Corcept Therapeutics Earnings - Frequently Asked Questions When is Corcept Therapeutics's earnings date? Corcept Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 4th, 2025 based off last year's report dates. Learn more on CORT's earnings history. What guidance has Corcept Therapeutics issued on next quarter's earnings? Corcept Therapeutics issued an update on its FY 2025 earnings guidance on Monday, May, 5th. The company issued revenue guidance of $900.0 million-$950.0 million, compared to the consensus revenue estimate of $905.4 million. Did Corcept Therapeutics beat their earnings estimates last quarter? In the previous quarter, Corcept Therapeutics (NASDAQ:CORT) reported $0.17 earnings per share (EPS) to hit the analysts' consensus estimate of $0.17. Learn more on analysts' earnings estimate vs. CORT's actual earnings. How can I listen to Corcept Therapeutics's earnings conference call? The conference call for Corcept Therapeutics's latest earnings report can be listened to online. Listen to Conference Call How can I read Corcept Therapeutics's conference call transcript? The conference call transcript for Corcept Therapeutics's latest earnings report can be read online. Read Transcript How much revenue does Corcept Therapeutics generate each year? Corcept Therapeutics (NASDAQ:CORT) has a recorded annual revenue of $685.45 million. How much profit does Corcept Therapeutics generate each year? Corcept Therapeutics (NASDAQ:CORT) has a recorded net income of $106.14 million. CORT has generated $1.16 earnings per share over the last four quarters. What is Corcept Therapeutics's price-to-earnings ratio? Corcept Therapeutics (NASDAQ:CORT) has a trailing price-to-earnings ratio of 60.49 and a forward price-to-earnings ratio of 56.04. What is Corcept Therapeutics's EPS forecast for next year? Corcept Therapeutics's earnings are expected to grow from $1.36 per share to $1.85 per share in the next year, which is a 36.03% increase. More Earnings Resources from MarketBeat Related Companies Royalty Pharma Earnings Results Jazz Pharmaceuticals Earnings Results Perrigo Earnings Results Supernus Pharmaceuticals Earnings Results Pacira BioSciences Earnings Results Omeros Earnings Results Nektar Therapeutics Earnings Results Assembly Biosciences Earnings Results Cumberland Pharmaceuticals Earnings Results Eli Lilly and Company Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Alibaba's Earnings Just Changed Everything for the StockCisco Stock Eyes New Highs in 2025 on AI, Earnings, UpgradesSymbotic Gets Big Earnings Lift: Is the Stock Investable Again?D-Wave Pushes Back on Short Seller Case With Strong EarningsAppLovin Surges on Earnings: What's Next for This Tech Standout?Can Shopify Stock Make a Comeback After an Earnings Sell-Off?Rocket Lab: Earnings Miss But Neutron Momentum Holds This page (NASDAQ:CORT) was last updated on 5/20/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredHow I profit during chaos…This Guy THRIVES on Chaos Wall Street legend Larry Benedict has thrived through every major market crash. I...Brownstone Research | SponsoredMemorial Day: 59% dividend from Bitcoin (No Crypto Needed)140% Dividends from stocks like Tesla? Discover How for Just $9! For Memorial Day, get the full details of ...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Corcept Therapeutics Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Corcept Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CORT Stock Free CORT Stock Alerts